trial

In Vivo Imaging of Therapeutic Electric Current Flow

NCTId NCT02453763
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 17 (actual)
Sponsored by University of Florida
Primary completion 2017-07-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
17 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2015-06
Primary completion
2017-07-06
Eligibility
ALL · 18 Years · 30 Years

Interventions & indications

Drugs
transcranial direct current stimulationMRI

Sponsors

University of FloridaLead Sponsor
Arizona State UniversityCollaborator
National Institute of Neurological Disorders and Stroke (NINDS)Collaborator

Investigators

1
Thomas Werge, Professor, Ph.D.Principal Investigator

Sites

1 total
Gainesville, United States

Facts & assertions

4 sourced
Enrollment
17
Phase
NA
Primary Completion Date
2017-07-06
Status
COMPLETED
relationships
The graph out of here
drug
transcranial direct current stimulation
drug
MRI
drug
lead_sponsor
University of Florida
company
collaborator
Arizona State University
company
National Institute of Neurological Disorders and Stroke (NINDS)
company
indication
Epilepsy
indication
Parkinson Disease
indication
Central Nervous System Diseases
indication
investigator
Thomas Werge, Professor, Ph.D.
person